NCT01017679
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China
Clinical trial condition
Non-small Cell Lung Cancer
Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1,335 public trials
329 recruiting studies
Non-small Cell Lung Cancer trial results
NCT00765687
- Conditions
- Bone Metastases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- SunYat-senU Guangzhou, Guangdong, China
NCT00322452
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Fuzhou, Fujian, China
- Research Site Guangzhou, Guangdong, China
- Research Site Wuhan, Hubei, China
- Research Site Nanjing, Jiangsu, China
NCT00828841
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Anniston, Alabama, United States
- Jonesboro, Arkansas, United States
- Anaheim, California, United States
- Azusa, California, United States
NCT01528488
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Department of Medical Oncology,Cancer Center of Sun Yat-Sen University Guangzhou, Guangdong, China
NCT00870532
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- National Cancer Centre, Singapore Singapore
NCT00636571
- Conditions
- Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Duke University Health System Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States
NCT00413283
- Conditions
- Blood Platelet Disorders, Bronchial Neoplasms, Cancer, +18 more
- Locations
-
- Research Site Glendale, Arizona, United States
- Research Site Glendale, Arizona, United States
- Research Site Anaheim, California, United States
- Research Site Anaheim, California, United States
Completed
Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC
NCT00633529
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Cancer Centers of Florida Ocoee, Florida, United States
- Central Indiana Cancer Centers Indianapolis, Indiana, United States
- New York Oncology Hematology P.C. Albany, New York, United States
- Mary Crowley Medical Research Center Dallas, Texas, United States
NCT00970580
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Resesarch Site Los Angeles, California, United States
- Resesarch Site San Diego, California, United States
- Resesarch Site Denver, Colorado, United States